Testing the Anti-inflammatory Effects of Curcuminoids in Patients with Colorectal Cancer

Methods Mol Biol. 2022:2343:319-330. doi: 10.1007/978-1-0716-1558-4_23.

Abstract

Colorectal cancer is the third most common cancer and accounts for the second highest number of cancer-related deaths worldwide. Natural products such as the turmeric-derived curcuminoids are known to have protective effects against several kinds of cancers by acting as antioxidant and anti-inflammatory agents. Here, we present a protocol for assessing the effects of curcuminoids on serum cytokine profiles in a double-blind placebo-controlled trial of patients with stage 3 colorectal cancer undergoing chemotherapy. The protocol could also be applied to other cancer types.

Keywords: Colorectal cancer; Curcumin; Curcuminoids; Cytokines; Inflammation; Turmeric.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Colorectal Neoplasms* / drug therapy
  • Curcuma
  • Diarylheptanoids
  • Humans
  • Randomized Controlled Trials as Topic

Substances

  • Anti-Inflammatory Agents
  • Diarylheptanoids